The Biomedical Zone was founded in 2015, with the goal of fostering and growing early-stage health technology companies. Two years prior, Ryerson University and St. Michael’s Hospital founded the Institute for Biomedical Engineering, Science and Technology (iBEST), a 20-year partnership focused on conducting biomedical research to advance healthcare.
As the commercialization arm of the partnership, the Biomedical Zone was founded on principles of biodesign. We apply a cross-disciplinary, team-based approach to finding need-based solutions to real clinical challenges. Our companies span medical devices, big data, health IT, simulation, and VR.
Our companies develop technology-based solutions to address significant global healthcare challenges. End users of the technologies include nurses, doctors, surgical residents, allied health professionals, and patients.
What We Offer
The Biomedical Zone is a physician-led, hospital-based health technology incubator in downtown Toronto. Our supportive, dynamic environment allows entrepreneurs to engage with like-minded innovators, while accessing dedicated clinical expertise and entrepreneurial resources from our partnerships with Ryerson University, the DMZ, Ryerson Futures Inc., and St. Michael’s Hospital. The Biomedical Zone offers the resources needed to accelerate product development from early prototype stages to commercialization. Our aim is to create scalable, sustainable healthcare solutions with global reach.
The Biomedical Zone is located in St. Michael’s Hospital at the Keenan Research Centre.